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In this issue of Cell Metabolism, Shibata et al. (2013) show that in renal intercalated cells mineralocorticoid
receptors phosphorylated on serine 843 are rendered active by angiotensin-induced dephosphorylation.
This finding represents a novel mechanism for regulating nuclear receptor activity, and explains the balance
between Na-Cl reabsorption in response to volume depletion and K+ excretion in response to potassium
loading.Terrestrial vertebrates evolved in a potas-
sium-rich, sodium-poor environment and
in consequence evolved mechanisms
(aldosterone activation of mineralocorti-
coid receptors [MR] in renal principal
cells) to conserve Na+ and excrete a K+
load. The organ principally responsible
for electrolyte homeostasis is the kidney,
which receives 20%–25% of the cardiac
output, thus filtering the entire blood vol-
ume every 4–5 min. Shibata et al. (2013)
now probe the mechanisms whereby
renal MR respond to the different chal-
lenges ofNa+ deficiency/volumedepletion
on the one hand and K+ loading on the
other.
Adosterone is secreted in response to
angiotensin II (volume depletion), elevated
plasma [K+] (potassium loading), and
(transiently) pituitary ACTH and activates
MR in the principal cells of the renal con-
necting tubule and collecting duct, at the
far end of the distal tubule. MR are curi-
ously promiscuous, binding with equal,
high-affinity aldosterone, cortisol (corti-
costerone in rats and mice), and (even
more curiously) progesterone, across a
range of species. In epithelia, MR are
selectively activated by aldosterone, re-
flecting coexpression of the enzyme
11bhydroxysteroid dehydrogenase type
2 (11bHSD2), which converts the 100-
fold higher intracellular concentrations
of cortisol to receptor-inactive cortisone.
Aldosterone, in contrast, is not a substrate
for 11bHSD2.
When aldosterone levels increase in
response to sodium or volume depletion,
MR act homeostatically to increase the
uptake of Na+ from tubular fluid into prin-cipal cells by activating epithelial sodium
channels (ENaCs). This is accompanied
by increased paracellular reabsorption
of Cl from tubular fluid, followed by acti-
vation of Na+/K+ ATPase in the contralu-
minal cell membrane to pump Na+ out
into extracellular fluid. In hyperkalemia,
part of the response is the same (ENaC
activation) and part is different, in that
hyperkalemia increases expression of
the ROMK potassium channel. Reab-
sorption of Na+ via ENaC produces an
electro-negative intraluminal potential,
thus driving increased K+ excretion via
the increased levels of ROMK. The ques-
tion then is, how can one receptor (MR)
elicit two different responses?
Shibata et al. (2013) now delineate the
MR-dependent mechanism to increase
Na+ reabsorption not via principal cells
but via intercalated cells in the renal
distal tubule. Under normal conditions,
MR in intercalated cells are phosphory-
lated on serine 843 and thus inacti-
vated. Dephosphorylation of MR S843P is
induced by angiotensin II via WNK4
signaling and activation of protein phos-
phatase 1 (PP1). In the presence of ligand,
dephosphorylated MR S843 increase
NaCl absorption and inhibit K+ secretion;
in contrast, hyperkalemia increases levels
of MR S843 phosphorylation in interca-
lated cells, which thus remain deaf to ste-
roid. Such receptor activation by revers-
ible phosphorylation in the ligand binding
domain, given that phosphorylated MR
are essentially inactive, is a new and
very exciting finding.
The study thus answers a number of
questions and prompts others. First isCell Metabolism 18,the mechanism of phosphorylation of
MR S843, in that the S835 phosphorylation
site matches no known kinase motif. Sec-
ond, the authors show that hyperkalemia
increases the levels of MR S843P: the
mechanism(s) involved may prove of
considerable (and more general) interest.
Third, though the authors showed no MR
S843P in brain, heart, colon, and aorta,
there remain other tissues worth investi-
gating. These include ovary and breast;
in both, the role of MR is likely to be other
than homeostatic. In the ovary the candi-
date ligand is probably progesterone; a
quick scan over the course of follicular
maturation might prove very interesting.
Roles of MR in the breast are yet to be
linked to the extraordinary physiology of
lactation. Milk is essentially collapsed
acinar cells, with [Na+] of 8 meq/L, un-
changed by elevated aldosterone levels
in Na+ deficiency. Recently, roles for MR
as a marker of disease-free interval
in breast cancer have been reported
(Muscat et al., 2013). In terms of lactation,
if a parallel with the intercalated cell ex-
ists, the ligand is likely to be cortisol, the
trigger prolactin rather than angiotensin
II, and cellular collapse rather than Na-Cl
transport the outcome. Again, a quick
look across pregnancy and lactation
may be worthwhile.
Finally, from the title onward, the
authors have aldosterone as the ste-
roid activating dephosphorylated MR
S843 in intercalated cells. This is based
on transgenic mouse (Tg WNK4Q562E)
studies with a gain-of-function mutation
mimicking human hyperkalemic hyper-
tension (PHA II). Such mice have a 62%November 5, 2013 ª2013 Elsevier Inc. 609
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wild-type, despite hyperkalemia which
normally elevates the level of phosphory-
lation. Very high levels of administered
aldosterone (>10-fold those in sodium
deficiency) elevated pendrin and BI H+
ATPase (MR-induced proteins) 2- to 3-
fold; equivalent doses in wild-type mice
produced little or no effect. This is alto-
gether unsurprising, given that the major-
ity of MR S843 were nonphosphorylated
in the transgenic mice; wild-type mice on
regular mouse chow have much higher
MRS843P (and thereforemuch lower levels
of activable MR S843) than the mutants.
I have no doubt that dephosphorylated
MR S843 in intercalated cells can be
activated by aldosterone. The authors
show equivalent activation by cortisol;
without any ‘‘protective’’ mechanism like
11bHSD, the default agonist in vivo is
therefore cortisol (corticosterone in the
mouse). This is not merely a default posi-
tion, but clearly supported by the different
phenotypes of the MR knockout (MRKO)
and the aldosterone synthase null
(AS/) mouse (Funder, 2006). MR are
clearly essential for Na+ homeostasis: on610 Cell Metabolism 18, November 5, 2013 ªa low salt intake, MRKO mice perish.
Aldosterone is not essential; in AS/
mice on a low salt intake, their blood pres-
sure falls slightly, their renin-angiotensin
system is markedly activated, they
become modestly hyperkalemic, but (in
the presence of glucocorticoids) they sur-
vive (Makhanova et al., 2006). Occam’s
razor would say that they are doing this
via their intercalated cells, with the very
elevated angiotensin overcoming the
modest hyperkalemia in terms of dephos-
phorylation of intercalated cell MR S843P,
and endogenous glucocorticoid then
allowing sufficient Na-Cl reabsorption to
maintain life.
The authors’ yoking the discovery of
a single phosphorylation site in the MR
ligand binding domain to solving a physi-
ological (and inevitably, clinical) conun-
drum is a masterstroke of translational
research. By showing the opposite effects
of angiotensin and hyperkalemia on MR
S843 phosphorylation, the authors have
elegantly demonstrated how these two
different stimuli can act via MR to main-
tain electrolyte homeostasis. Given the
absence of 11bHSD2 from intercalated2013 Elsevier Inc.cells, the ligand for dephosphorylated
MR S843 is presumptively cortisol rather
than aldosterone. If this is the case, the
authors have solved not one but two
enigmas. The first is theMR-mediated dif-
ferential response to volume depletion
and potassium loading; the second is
the different response to sodium restric-
tion in the MRKO and AS/ mouse.
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The Nlrp3 inflammasome is a key controller of the proinflammatory cytokine IL-1b. Iyer and colleagues (2013)
demonstrate that Nlrp3 activators promote an interaction between cardiolipin in mitochondria and Nlrp3.
Cardiolipin is thus a hydrophobic danger signal that, upon translocation to the outer mitochondrial mem-
brane, activates Nlrp3, promoting inflammation.The Nlrp3 inflammasome is a multiprotein
complex that regulates caspase-1, the
protease that processes pro-IL-1b into its
mature form. Given the importance of IL-
1b as a proinflammatory cytokine, there
has been interest in understanding the
regulation of Nlrp3. Studies in Nlrp3-defi-
cient mice as well as humans all point
to Nlrp3 as an important driver of inflam-
matory diseases as diverse as type 2
diabetes, Alzheimer’s disease, and gout(Wen et al., 2012). Nlrp3 can be activated
by a wide range of stimuli, including
particles such as uric acid, islet-associ-
ated polypeptide, b-amyloid and silica,
as well as factors such as ATP acting via
the P2X7 receptor. This diversity of stimuli
has presented a challenge concerning the
mechanism of activation. A common fea-
ture appears to be the generation of
reactive oxygen species (ROS) by mito-
chondria (Zhou et al., 2011), althoughhow ROS actually impacts Nlrp3 is not
known. In a recent paper in Immunity, Iyer
and colleagues provide a new piece in the
puzzle of Nlrp3 activation, identifying the
mitochondrial phospholipid cardiolipin
as an activator of Nlrp3, operating down-
stream of ROS (Iyer et al., 2013). Of inter-
est, cardiolipin acts as a classic danger
signal, given that it appears on the outer
membrane of mitochondria only when
the mitochondria become dysfunctional.
